Patients’ preferences for atopic dermatitis treatments in Europe: a discrete choice experiment
This study identified most important treatment attributes for AD patients. It could improve AD patients' access to suitable therapies as findings might support development of better aligned treatments and provide new perspectives for joint treatment decision-making. Main limitation was low number of participants, although significant results were still achieved.
Authors
- Axel De Greef (ORCID: https://orcid.org/0000-0003-0713-8283)
- Charlotte Beaudart (ORCID: https://orcid.org/0000-0002-0827-5303)
- Mickaël Hiligsmann (ORCID: https://orcid.org/0000-0003-4274-9258)
- Olivier Vanhooteghem (ORCID: https://orcid.org/0000-0001-7191-2566)
- Antoni Gostyński (ORCID: https://orcid.org/0000-0002-1091-2914)
- Katja C. Heinz (ORCID: https://orcid.org/0009-0002-2148-0675)
Institutions
- Cliniques Universitaires Saint-Luc (BE)
- University of Namur (BE)
- Maastricht University Medical Centre (NL)
- Maastricht University (NL)
- CHU Dinant Godinne UCL Namur (BE)
- UCLouvain (BE)
Publication Details
- Journal
- Expert Review of Pharmacoeconomics & Outcomes Research
- Published
- 2025-11-26
- DOI
- https://doi.org/10.1080/14737167.2025.2594633
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00